Presentation is loading. Please wait.

Presentation is loading. Please wait.

Effects of insulin administration in streptozotocin-treated mice.

Published byΛευκοθέα Κοντολέων Modified over 5 years ago

Similar presentations

Presentation on theme: "Effects of insulin administration in streptozotocin-treated mice."— Presentation transcript:

1 Effects of insulin administration in streptozotocin-treated mice.
Effects of insulin administration in streptozotocin-treated mice. A: Mice were treated with streptozotocin, and after 3 days, insulin was administered (5 IU/kg i.p.; 0, 5, 15, and 30 min), and protein extracts of the cerebral cortex were immunoblotted for site-selective tau phosphorylation and total tau. B: Insulin was administered to control or streptozotocin-treated mice, and PP2A activity was measured. Quantitative values are means ± SE from four mice per group. *P < 0.05 compared with control values. Buffie J. Clodfelder-Miller et al. Diabetes 2006;55: ©2006 by American Diabetes Association

Download ppt "Effects of insulin administration in streptozotocin-treated mice."

Similar presentations

Effect of N-WASp glutathione-S-transferase (GST) fusion proteins on force in tracheal muscle strips stimulated with 10−5 M ACh under isometric conditions.

Effect of N-WASp glutathione-S-transferase (GST) fusion proteins on force in tracheal muscle strips stimulated with 10−5 M ACh under isometric conditions.
SCC244 significantly inhibited c-Met–driven tumor growth in cancer CDX models. SCC244 significantly inhibited c-Met–driven tumor growth in cancer CDX models.

SCC244 significantly inhibited c-Met–driven tumor growth in cancer CDX models. SCC244 significantly inhibited c-Met–driven tumor growth in cancer CDX models.
Inhibition of CR HCT-116 (A and B) or CR HT-29 cells (B) xenografts in EPA and/or FuOx-treated SCID mice. Inhibition of CR HCT-116 (A and B) or CR HT-29.

Inhibition of CR HCT-116 (A and B) or CR HT-29 cells (B) xenografts in EPA and/or FuOx-treated SCID mice. Inhibition of CR HCT-116 (A and B) or CR HT-29.
Phosphorylation and sequence disorder in microtubule-associated protein Tau.A, schematic illustration of the domain profile of Tau with all known phosphorylation.

Phosphorylation and sequence disorder in microtubule-associated protein Tau.A, schematic illustration of the domain profile of Tau with all known phosphorylation.
Insulin content of isolated pancreas and islet morphology.

Insulin content of isolated pancreas and islet morphology.
Impact of U-100 RHI administered with V-Go at OV1 (3 months after initiation) and OV2 (6 months after initiation) (n = 11) at 3 months (P = 0.32) and at.

Impact of U-100 RHI administered with V-Go at OV1 (3 months after initiation) and OV2 (6 months after initiation) (n = 11) at 3 months (P = 0.32) and at.
Change in random blood glucose level, body weight, and intraperitoneal glucose tolerance test (IPGTT) in streptozotocin (STZ)-induced diabetic mice. Change.

Change in random blood glucose level, body weight, and intraperitoneal glucose tolerance test (IPGTT) in streptozotocin (STZ)-induced diabetic mice. Change.
Distribution of phosphosites and PDGFRα activity in primary cultures.

Distribution of phosphosites and PDGFRα activity in primary cultures.
BTG2 regulates gluconeogenic gene expression in diabetic mouse models

BTG2 regulates gluconeogenic gene expression in diabetic mouse models
NOx ASR (in mmol/day), arginine Ra (in µmol/kg × min), the fraction of arginine flux converted to NOx (%), and the insulin-mediated glucose disposal (M)

NOx ASR (in mmol/day), arginine Ra (in µmol/kg × min), the fraction of arginine flux converted to NOx (%), and the insulin-mediated glucose disposal (M)
Overexpression of BTG2 resulted in an increase in hepatic gluconeogenesis. Overexpression of BTG2 resulted in an increase in hepatic gluconeogenesis. A:

Overexpression of BTG2 resulted in an increase in hepatic gluconeogenesis. Overexpression of BTG2 resulted in an increase in hepatic gluconeogenesis. A:
Effect of insulin on hepcidin expression in HepG2 cells.

Effect of insulin on hepcidin expression in HepG2 cells.
Comparison of the protective effects of R and S isomers of LA on insulin-stimulated 2-DG uptake. Comparison of the protective effects of R and S isomers.

Comparison of the protective effects of R and S isomers of LA on insulin-stimulated 2-DG uptake. Comparison of the protective effects of R and S isomers.
Effects of streptozotocin treatment on several kinases that can phosphorylate tau. Effects of streptozotocin treatment on several kinases that can phosphorylate.

Effects of streptozotocin treatment on several kinases that can phosphorylate tau. Effects of streptozotocin treatment on several kinases that can phosphorylate.
Streptozotocin treatment increased phospho–Thr231-tau immunoreactivity in mouse brain. Streptozotocin treatment increased phospho–Thr231-tau immunoreactivity.

Streptozotocin treatment increased phospho–Thr231-tau immunoreactivity in mouse brain. Streptozotocin treatment increased phospho–Thr231-tau immunoreactivity.
Changes (mean +SEM) in glucose, insulin, glucagon-like peptide (GLP)-1 and ghrelin from the baseline values after administration of placebo (broken lines.

Changes (mean +SEM) in glucose, insulin, glucagon-like peptide (GLP)-1 and ghrelin from the baseline values after administration of placebo (broken lines.
Exogenous CRP administration causes fasting hyperglycemia and hyperinsulinemia without altering body composition. Exogenous CRP administration causes fasting.

Exogenous CRP administration causes fasting hyperglycemia and hyperinsulinemia without altering body composition. Exogenous CRP administration causes fasting.
1018-NT-β-cell clusters protect mice from STZ-induced diabetes.

1018-NT-β-cell clusters protect mice from STZ-induced diabetes.
Omental FFA production, calculated from the integrated lipolysis over the last 30 min of each insulin infusion period. Omental FFA production, calculated.

Omental FFA production, calculated from the integrated lipolysis over the last 30 min of each insulin infusion period. Omental FFA production, calculated.
Glucose infusion rate required to maintain the hyperglycemic clamp during the experimental period in sedentary and exercised dogs receiving basal or elevated.

Glucose infusion rate required to maintain the hyperglycemic clamp during the experimental period in sedentary and exercised dogs receiving basal or elevated.

Similar presentations

Ads by Google